secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-09-12T23:59:59+00:00
Accession:  0001493152-24-035939
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics posts presentation on antitumor virotherapies after RedChip webinar
--------------------------------------------------------------------------------

- Presentation titled 'Systemic and Localized Antitumor Virotherapies' referenced during September 11, 2024 RedChip webinar.
- Webinar webcast available on Company's website Events and Presentation page.
- No specific financial, clinical, or operational updates disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224035939/0001493152-24-035939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224035939/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-035939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer